You are here

Sage online ordering services are currently unavailable due to network disruption. We are working to restore service as soon as possible. In the meantime, our books are still available widely via retailers and online. Currently we are only able to supply digital inspection copies. These can be requested via this site, or direct from Vitalsource and Kortext. If you need a print copy, please contact your local Academic Sales Consultant, who will be able to arrange to send this once our systems are back online.

If you need further assistance please visit our Contact us page for further information. Thank you for your patience and we apologise for the inconvenience.

Breast Cancer: Basic and Clinical Research

Breast Cancer: Basic and Clinical Research


eISSN: 11782234 | ISSN: 11782234 | Current volume: 17 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Published by SAGE since 2016.
  • Gold open access format, driving high visibility and global exposure.
  • Rigorous peer review.
  • Listed in PubMed and freely available via PubMed Central.
  • Indexed in: Clarivate Analytics: Emerging Sources Citation Index (ESCI), EBSCO, Scopus, and PubMed Central.

Breast Cancer: Basic and Clinical Research is a peer-reviewed open access journal that covers all aspects of research and treatment of breast cancer. The journal aims to promote understanding of breast cancer biology and pathogenesis, clinical interventions, and epidemiology and population genetics. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

Diversity, Equity and Inclusion Statement

Breast Cancer: Basic and Clinical Research promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the breast cancer community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at https://mc.manuscriptcentral.com/bcb.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Open access information

The article processing charge (APC) for this journal is 2650 USD.

The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is also subject to taxes where applicable. Please see further details here.

Contact

Please direct any queries to BCB@sagepub.com.

Breast Cancer: Basic and Clinical Research delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to all areas of breast cancer research and treatment. The journal is aimed at an international audience of clinicians and researchers in breast cancer, providing an online forum for rapid dissemination of recent research and perspectives in this area.

Specific areas of interest include, but are not limited to, breast cancer sub types, pathobiology, metastasis, genetics and epigenetics, mammary gland biology, breast cancer models, prevention, detection, therapy and clinical interventions, and epidemiology and population genetics.

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

The journal adheres to an anonymized review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.

 

Editor-in-Chief
Goberdhan P. Dimri, PhD George Washington University Medical Center, Washington, DC, USA
Managing Editor
Lingling Tian, PhD SAGE Publishing, Shanghai, China
Biostatistical Editors
Xueliang (Jeff) Pan PhD Department of Biomedical Informatics, The Ohio State University,USA
Muni Rubens MD, MPH, PhD Miami Cancer Institute,USA
Editorial Board Member
Vimla Band PhD University of Nebraska Medical Center, Omaha, Nebraska, USA
Alakananda Basu PhD University of North Texas Health Science Center, Fort Worth, Texas, USA
Amy H. Bouton PhD University of Virginia School of Medicine, Charlottesville, Virginia, USA
Robert Clarke PhD, DSc Hormel Institute at the University of Minnesota
Stella D'Oronzo MD, PhD Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy
Gianluca Franceschini, MD Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Nick Gebruers PT, PhD Department of rehabilitation sciences, University of Antwerp, Antwerp, Belgium
Sandra J. Gendler PhD Mayo Clinic College of Medicine, Scottsdale, Arizona, USA
William E. Grizzle MD, PhD University of Alabama at Birmingham, Birmingham, Alabama, USA
Kalpna Gupta PhD University of Minnesota, Minnesota, USA
Allan D. Hess PhD Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA
Jennifer J. Hu PhD University of Miami Miller School of Medicine, Miami, Florida, USA
Huabei Jiang PhD University of Florida, Gainesville, Florida, USA
H. Phillip Koeffler MD UCLA School of Medicine, Hematology/Oncology Division, Cedars-Sinai Medical Center, California, USA
Robert A. Kurt PhD Lafayette College, Easton, Pennsylvania, USA
Lee Jane W. Lu PhD The University of Texas Medical Branch, Galveston, Texas, USA
Mia K. Markey PhD The University of Texas at Austin, Department of Biomedical Engineering, Austin, Texas, USA
See Mee Hoong MD, MSurg Department of Surgery, University of Malaya, Kuala Lumpur, Malaysia
Rajendra G. Mehta PhD Illinois Institute of Technology, Chicago, Illinois, USA
William George North PhD Dartmouth Medical School, Lebanon, New Hampshire, USA
Fernando Petracci MD, MSc Breast Cancer Department, Instituto Alexander Fleming, Buenos Aires, Argentina
Ajay Rana PhD University of Illinois at Chicago, Chicago, Illinois USA
Michael A. Tainsky PhD Wayne State University School of Medicine, Detroit, Michigan, USA
Valerie Marie Weaver PhD University of California, San Francisco, CA, USA
Ray-Chang Wu PhD George Washington University Medical Center, Washington, DC, USA
  • Clarivate Analytics: Emerging Sources Citation Index (ESCI)
  • Directory of Open Access Journals (DOAJ)
  • EBSCO
  • ProQuest
  • PubMed Central (PMC)
  • Scopus
  • Manuscript submission guidelines can be accessed on Sage Journals.